BioCentury
ARTICLE | Politics & Policy

PTAB sovereign immunity likely to move to federal courts

February 26, 2018 6:26 AM UTC

The Patent Trial and Appeal Board has rejected an attempt by Allergan plc (NYSE:AGN) to shield patents on Restasis cyclosporine from an inter partes review challenge by transferring them to the Saint Regis Mohawk tribe.

PTAB ruled that the tribe is not entitled to assert sovereign immunity in inter partes review proceedings. ...